Details for Patent: 8,827,963
✉ Email this page to a colleague
Which drugs does patent 8,827,963 protect, and when does it expire?
Patent 8,827,963 protects BYDUREON PEN and is included in one NDA.
Protection for BYDUREON PEN has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has four patent family members in four countries.
Summary for Patent: 8,827,963
| Title: | Administering device with holding mechanism |
| Abstract: | An apparatus for administering a substance, e.g. a medicinal, pharmaceutical, or cosmetic substance, includes a driving member movably mounted within the apparatus to administer the substance, and the driving member includes a holding feature or components of a holding feature which holds or retains at least one additional element of the apparatus in a position relative to the apparatus. In some embodiments, the additional element is a carpule or ampoule containing the substance, and the holding feature retains the carpule or ampoule in a position within a carpule or ampoule holder. |
| Inventor(s): | Hirschel; Juerg (Aarau, CH), Kaenel-Jost; Celine (Zurich, CH), Moser; Ulrich (Heimiswil, CH), Tschirren; Markus (Kirchberg, CH) |
| Assignee: | TecPharma Licensing AG (Burgdorf, CH) |
| Application Number: | 12/853,713 |
|
Patent Claim Types: see list of patent claims | Device; |
Drugs Protected by US Patent 8,827,963
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca Ab | BYDUREON PEN | exenatide synthetic | FOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS | 022200-002 | Feb 28, 2014 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,827,963
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Switzerland | 0188/08 | Feb 11, 2008 |
International Family Members for US Patent 8,827,963
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| China | 101998870 | ⤷ Try a Trial | |||
| European Patent Office | 2252351 | ⤷ Try a Trial | |||
| Poland | 2252351 | ⤷ Try a Trial | |||
| World Intellectual Property Organization (WIPO) | 2009100549 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
